33 results on '"Vavricka, Stephan R."'
Search Results
2. Pneumocystis jirovecii Pneumonia in Patients with Inflammatory Bowel Disease–a Case Series.
3. Energy Drink Administration Ameliorates Intestinal Epithelial Barrier Defects and Reduces Acute DSS Colitis.
4. Varicella Zoster Virus in Inflammatory Bowel Disease Patients: What Every Gastroenterologist Should Know.
5. Diagnosis and Outcome of Oesophageal Crohn's Disease.
6. Interstitial and Granulomatous Lung Disease in Inflammatory Bowel Disease Patients.
7. Early Initiation of Anti-TNF is Associated with Favourable Long-term Outcome in Crohn's Disease: 10-Year-Follow-up Data from the Swiss IBD Cohort Study.
8. ECCO-ESGAR Guideline for Diagnostic Assessment in IBD Part 2: IBD scores and general principles and technical aspects.
9. ECCO-ESGAR Guideline for Diagnostic Assessment in IBD Part 1: Initial diagnosis, monitoring of known IBD, detection of complications.
10. The Relevance of Vitamin and Iron Deficiency in Patients with Inflammatory Bowel Diseases in Patients of the Swiss IBD Cohort.
11. Colectomy Rates in Ulcerative Colitis are Low and Decreasing: 10-year Follow-up Data From the Swiss IBD Cohort Study.
12. Expression Patterns of TNFα, MAdCAM1, and STAT3 in Intestinal and Skin Manifestations of Inflammatory Bowel Disease.
13. Prdx6 Deficiency Ameliorates DSS Colitis: Relevance of Compensatory Antioxidant Mechanisms.
14. Anti-TNF Treatment for Extraintestinal Manifestations of Inflammatory Bowel Disease in the Swiss IBD Cohort Study.
15. 3rd European Evidence-based Consensus on the Diagnosis and Management of Crohn's Disease 2016: Part 2: Surgical Management and Special Situations.
16. Experts Opinion on the Practical Use of Azathioprine and 6-Mercaptopurine in Inflammatory Bowel Disease.
17. The First European Evidence-based Consensus on Extra-intestinal Manifestations in Inflammatory Bowel Disease.
18. Cogan's Syndrome in Patients With Inflammatory Bowel Disease - A Case Series.
19. High Rates of Smoking Especially in Female Crohn's Disease Patients and Low Use of Supportive Measures to Achieve Smoking Cessation--Data from the Swiss IBD Cohort Study.
20. Extraintestinal Manifestations of Inflammatory Bowel Disease.
21. Chronological Order of Appearance of Extraintestinal Manifestations Relative to the Time of IBD Diagnosis in the Swiss Inflammatory Bowel Disease Cohort.
22. Prevalence and Risk Factors for Therapy Escalation in Ulcerative Colitis in the Swiss IBD Cohort Study.
23. High altitude journeys and flights are associated with an increased risk of flares in inflammatory bowel disease patients.
24. Bilberry ingestion improves disease activity in mild to moderate ulcerative colitis — An open pilot study.
25. Systematic assessment of factors influencing preferences of crohn's disease patients in selecting an anti-tumor necrosis factor agent (CHOOSE TNF TRIAL).
26. Protein tyrosine phosphatase nonreceptor type 2 regulates autophagosome formation in human intestinal cells.
27. Systematic evaluation of risk factors for diagnostic delay in inflammatory bowel disease.
28. Efficacy and safety of certolizumab pegol in an unselected crohn's disease population: 26-week data of the FACTS II survey.
29. Association between Cogan's syndrome and inflammatory bowel disease: A case series.
30. Prevalence of anaemia in inflammatory bowel disease in Switzerland: A cross-sectional study in patients from private practices and university hospitals
31. Efficacy and safety of certolizumab pegol induction therapy in an unselected Crohn's disease population: Results of the FACTS survey.
32. Simple and Simply the Best? Dublin in the European Spotlight.
33. European Crohn's and Colitis Organisation Topical Review on Complementary Medicine and Psychotherapy in Inflammatory Bowel Disease.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.